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ABSTRACT
Internal parasitism inevitability prompts economic loss in beef cattle production by decreasing
growth performance and reproductive traits. Today, the most widely used class of anthelmintic
used to treat parasitism, is the macrocyclic lactone. Many studies have conflicting results on the
efficacy of macrocyclic lactones (ML) efficacy against internal parasitism. The objective of this
study was to evaluate the effectiveness of moxidectin and eprinomectin, two of the MLs, on cow
performance. Multiparous fall calving, crossbred beef cows (n = 106) were allocated randomly to
1 of 3 anthelmintic treatments: 1) Negative control (CON), in which cows did not receive an
anthelmintic, 2) Injectable moxidectin (MOX) and 3) Injectable extended release eprinomectin
(ERE). Anthelminthic administration occurred on d 0, just prior to calving. Body weights (BW),
body condition scores (BCS), and fecal egg counts (FEC) were obtained throughout the duration
of the calving season until weaning, occurring on days: 0, 80, 162, and 217, with weaning
occurring on d217. FEC were obtained, and body weights were recorded for calves on d162 and
d 217.Performance data were analyzed using the MIXED procedures of SAS, and pregnancy
data were analyzed using the GENMOD procedures of SAS. Significance was fixed at P < 0.05
and tendencies were established from 0.05 ≤ P ≤ 0.10. There was no effect of anthelmintic
treatment on cow BW (P ≥ 0.57) or cow BCS (P ≥ 0.22) during the 217 d study; however, CON
cows tended to have lower BCS (P = 0.08) throughout the duration of the study. Cows treated
with ERE had lower FEC compared to MOX and CON groups (P ≤ 0.001), as well as a tendency
for improved pregnancy (2 = 0.0735), and calving (2 = 0.007) rates compared to the MOX
treated group. Calf average daily gain (P = 0.23) and weaning weight (P = 0.35) was similar
regarding CON, MOX, and ERE dam treatments. Calf fecal egg counts tended to differ in
relation to dam treatment on d 162 (P = 0.08) regarding CON, MOX, and ERE cow treatments.
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INTRODUCTION
There is an unquestionable certainty of negative effects and financial loss associated with
internal parasitism in beef cattle productivity. Losses that are inherently common to parasitism
include decreases in body weight gains, milk production, reproductive rates and body condition
scores. This, in combination with decreased feed intake, inhibition of nutrient utilization,
metabolism disruption and declining immune status of the animal further compounds the losses
endured both physically by the animal, and financially by the producer (Kunkle et al., 2013).
Actions advised for negating these parasite- associated production losses include strategic
pasture rotation management practices, keeping animals in a good nutritional status and the
correct use of anthelminthic products, taking into account treatment timing, product selection,
and administration. The objective of this study was to evaluate the efficacy of two commercially
available anthelmintic products on cow and calf performance measurements in a fall calving beef
herd located at the University of Arkansas Cow Calf unit in Savoy, AR.
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LITERATURE REVIEW
Trichostrongylus spp.
Trichostrongylids, more commonly known as Trichostrongyles, belong to the
superfamily Trichostrongylicae. The nematodes within this superfamily are known for their
small mouths, slender bodies, and similar life cycles. These parasites can measure anywhere
between 450-20,000 microns, which are species and stage dependent. Trichostrongyles are
considered to be the most important nematodes in ruminants due to the high level of
pathogenicity they can achieve within the animal. Mixed infections are the norm, so it is hard to
distinguish which species cause particular symptoms, due to the shared spectrum of affects and
pathogenicity. Some of the most common genera in this family that can infect cattle include:
Trichostrongylus spp., Haemonchus sp. , Cooperia spp. , Ostertagia sp. and Nematodirus sp.
(Levine 1968; Cydectin Pour On Technical Manual,1998).
Trichostrongylus Life cycle
Levine (1968) describes the life cycle of the Trichostrongylus type worms as being
mostly the same with some variability between species. Generally, the adult worms will produce
eggs that will be excreted within the feces of the animal into the environment. Depending on
whether environmental conditions are conducive enough to provide suitable oxygen, water and
appropriate temperature, the egg will take about a day or more before hatching a first stage
rhabditiform larva (L1).
These (L1) larvae survive by feeding on bacteria and other microorganisms that are in the
surrounding fecal pat for a day or more and if conditions are still favorable they will molt into a
second stage larvae (L2). The L2 will continue to feed on the bacteria and other microorganisms
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around them for a few days until they molt into a third stage ensheathed infective stage larvae
(L3).
The total time from egg excretion within the feces into an infective L3 larvae can take as
little as 6 days or as long as several weeks depending on temperatures and other microclimatic
affects that can interfere with development. Once the larvae have reached the L3 stage they
migrate out of the fecal pat where many crawl up vegetation or stay on the soil’s uppermost
surface. During this time, the ensheathed larvae can survive from days to months, utilizing food
material stored in their cells. When a suitable hosts ingests the L3, the nematode will undergo
exsheathment of their cuticle and will begin the parasitic phase of the life cycle in the
gastrointestinal tract of the animal. At this point, depending on the species, larvae can begin
exhibiting feeding behavior whether that is consuming tissue or taking blood meals from the host
animal. The larvae molt twice more, once into a fourth stage larvae (L4) , and then finally into
adolescent L5’s , just prior to development into mature adult worms.
The adult worms will continue to remain in their designated region within the
gastrointestinal tract and reproduce. The species of the nematode determines the expected time it
may take to develop into a reproductively capable adult, which is termed pre-patency as well as
determine the time frame in which the adult is actively reproducing within the host, otherwise
known as patency. There are many factors which can influence this timeline as well, such as:
season of the year, intraburden inhibition, age,sex, species, and previous infection history of the
host animal.
Furthermore, nematode egg survival within the environment can also influence the
epidemiological cycle of a host animal becoming infected. Evidence of microclimatic effects on
development of bovine nematode eggs were observed by Rossanigo and Gruner (1994) in a study
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done in central west Argentina where fecal pats were placed in three different environments (sun,
shade, and the laboratory) during three seasons of the year (summer, autumn, and fall). In this
study, mean temperature and fecal water content (FWC) inside the pats were measured in order
to determine effect on larval rates of development.
The genera of nematode eggs used in this study included: Haemonchus, Cooperia,
Ostertagia and Oseophagostomum. The rate of development of larvae was demonstrated by the
number of L3, which were extracted via the Baermann procedure, per 100 eggs deposited within
the fecal pats.
It was observed that 78% of the variability of development of all genera nematode eggs
into L3 larvae was explained by the following three variables: the mean temperature during the
total duration of development, the mean temperature during the first one-third of the duration of
total development and the minimal fecal water content.
In regards to Haemonchus species in particular, the mean temperature value and the
minimal value of FWC explained 54% of the variability for the development of L3 larvae.
Whereas, the mean maximal temperature and the minimal FWC values were the two main
factors that determined the development of Cooperia species. Overall, developmental rates were
higher in pats that were located in the shade during the summer and highest in locations that
experienced more sunshine during the autumn season ; whereas, the laboratory conditions
yielded more variability with its results on rate of development (Rossangio and Gruner,1994).
Important Internal Parasites of Cattle
Cooperia spp.
There are many different species of Cooperia that affect cattle, some of the most common
are: C. punctata, C. pectinata, C. surnabada and C oncophora. Cooperia spp. cause
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gastrointestinal inflammation/damange by penetrating the small intestine mucosa and causing
acute inflammation, which increases the mucus production within the intestinal tract. Some
animals may present with thickened mucosa accompanied by purple colored lesions upon
necropsy (Cydectin Pour On Technical Manual, 1998).
Cooperia is most pathogenic when it is present in young calves and causes clinical
symptoms of: enteritis, diarrhea, emaciation and death. In a study by Alicata and Lynd (1961),
five calves were experimentally administered 250,000 C. punctata larvae and five calves were
left to serve as the control group in order to measure growth rates and observe other signs of
infection. The resulting clinical signs of infection consisted of soft feces, intermittent or
continued diarrhea, progressive emaciation, reduced feed consumption, weight loss and
listlessness in infected calves.
Nematodirus helvetianus
Nematodirus, known as the thread necked worm, resides exclusively in the small intestine
of young cattle. Its eggs are easily distinguishable from the other trichostrongyle type eggs, due
to it’s larger size and football shape. In heavy infections L4 larvae and adults cause the atrophy
of villi and inflammation within the intestine (Cydectin Pour On Technical Manual, 1998). This
results in disruption of digestive function and negatively affects nutrient absorption. The
common signs associated with an infection of N. helvetianus are anorexia, diarrhea, and
depressed growth (Williams, 1988).
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The HOT Complex
Of the various nematode species that are found within the gastrointestinal tract of cattle,
some of the most important are those that are known to comprise the ‘HOT’ complex. This
complex includes the genera: Haemonchus sp., Ostertagia sp., and Trichostrongylus spp.
(Emery, 1996).
Haemonchus placei
Haemonchus, commonly called the barberpole worm, draws a large amount of blood
from the animal in the L4 and adult stages during its life cycle within the host animal (Cydectin
Pour On Technical Manual, 1998). They are particularly known for injecting an anticoagulant
into the place of attachment at the mucosal surface so that the host loses more blood, usually
more than the worm can physically ingest. This explains the hemorrhagic nature of the intestines
commonly found upon necropsy in the host animal. Animals infected with large numbers usually
show signs of: anemia, edema, emaciation, submandibular swelling, weakness, pale mucus
membranes and weight loss (Levine,1968).
Ostertagia ostertagi
Ostertagia, commonly known in cattle as the brown stomach worm, is also a blood
sucking nematode in all larval and adult stages of its life cycle and is considered to be the most
important cattle parasite in the United States (Cydectin Pour On Technical Manual, 1998). There
are three types of ostertagiasis that present in cattle, where Type 1 ostertagiasis consists of the
classic disease in calves that display diarrhea and weight loss when exposed to the parasites for
the first time on pasture. The ingested larvae in these calves develop to mature adults in about 21
days (Martin et al., 1957; Anderson et al., 1965).
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Pre-type 2 ostertagiasis occurs when the infective larvae are picked up during the grazing
season and arrest within the abomasal wall for extended periods as opposed to continued
development (type 1). This arrestment is due to Ostertagia’s ability to sense that the environment
outside the host is not suitable for larval development and/or survival. In northern climates, this
occurs in the autumn and winter, and in the southern regions, it occurs in late spring and most of
the summer (Cydectin Pour on Technical Manual, 1998).
Type 2 ostertagiasis is a condition that transpires when previously arrested larvae are
signaled to continue their course of maturation. This occurs in the late winter and early spring in
the north, and in the south it occurs during fall. During this time, a large amount of the
previously arrested pre-type 2 larvae become active in the abomasal mucosa, causing immense
tissue damage, inflammation, fluid loss, and hyperemia. Acute and abrupt symptoms similar to
Type 1 ostertagiasis, such as diarrhea, weight loss, and subcutaneous swelling will also arise.
The morbidity and mortality levels associated with this disease are largely dependent on the level
of infection and magnitude of emergence of the previously arrested larvae in the type 2 disease
state. (Cydectin Pour On Technical Manual, 1998; Martin et al., 1957; Anderson et al., 1965;
Myers and Taylor, 1989).
Trichostrongylus axei
According to Levine (1968), T. axei can be highly pathogenic in large numbers. Once
ingested, T. axei larvae migrate to the abomasal mucosa where they cause lesions, which
contribute to mucosa inflammation, hyperemia and sloughing of the epithelial tissue that lines
the intestinal tract. Doran (1955) found infections of T. axei to cause weight loss, loss of appetite,
watery diarrhea and in some cases resulted in the death of calves.
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Other, Less Common Parasites of Concern in Cattle
Bunostomum phlebotomum
Bunostomum, also known as the cattle hookworm, enter the host by skin penetration
before migrating to the host’s small intestine. As described by Levine (1968), the first sign of
Bunostomum phlebotomum infection is hives, skin irritations, and animals itching their lower
legs due to larval entrance through skin penetration, when the infection is percutaneous. Animals
will later become anemic and experience diarrhea due to the blood sucking nature of the adult
worms within the small intestine. The intestinal mucosa will become fluid filled and may or may
not be accompanied with blood. Clinical signs are mostly observed in calves, as adult animals
commonly acquire immunity due to previous infections (Cydectin Pour On Technical Manual,
1998).
Oesophagostomum radiatum
Commonly referred to as the nodular worm, O. radiatum is unlike Bunostomum in that
the majority of the pathogenicity and intestinal destruction that the animal endures is due to the
pre-patent larvae and not the actively reproductive adult worms (Cydectin Pour On Technical
Manual, 1998). This nematode can infect the animal upon ingestion, or via skin penetration.
According to Andrews and Maldonado (1942) and Mayhew (1948), the 4th stage larvae
become encapsulated in nodules in the mucosa within the small and large intestine. These small
raised areas grow over time to form abscesses, which may be fluid filled and may contain blood.
These nodules eventually cause the intestinal tract to become greatly inflamed, and with repeated
infections can be severe to the animal’s health. The animal may then experience upset to their
normal digestive functions and present with severe diarrhea and anorexia.
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Monezia benedini
Monezia is a helminth of the family Cestoda or more commonly known as tapeworms.
Pathogenicity is fairly low and usually does not cause a major concern in the health of cattle
unless found in large numbers. Tapeworm infections in cattle occur by cattle ingestion of an
infected free-living mite on pasture. The mite serves as an intermediate host where the larval
stage of the tapeworm occurs within the mite. Once the cattle ingest the mite, the larva are
released from the digested mite and attach to the mucosa of the small intestine. The tapeworm
will continue a process called strobilation until it reaches full maturity. At this time, the adult
tapeworm will shed eggs, or gravid proglottids from the posterior end of the tapeworm. These
shed eggs are ingested by a free-living mite which commences the life cycle of a new tapeworm.
Tapeworms do not cause severe intestinal trauma in cattle. There have been some
observed negative effects of tapeworm burdens in calves, including intestinal irritation, and
digestion issues with resulting diarrhea and unthriftiness (Porter, 1942).
Coccidia
The term coccidia is the common name used to describe the single cell protozoan parasite
known as Eimeria spp. that is often observed in ruminant animals. These parasites are normally
not a concern with grazing cattle, as they do not usually cause clinical signs of disease even in
high numbers, but in some instances, as with young or stressed animals, they cause mucosal
tissue destruction, erosion, and petechial hemorrhage (Jolley and Bardsley, 2006). According to
Matjila and Penzhorn, (2002) the estimated annual loss that cattle ranchers endure due to
coccidiosis reaches upwards of $400 million due to reduced feed efficiency, stunted weight gain
and increased likelihood of contracting other diseases.
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These coccidian parasites develop in the intestinal cells of the animals, and complete an
elaborate life cycle eventually resulting in the voiding of oocysts into the feces. If environmental
conditions are favorable, these oocysts can survive on vegetation, water sources, and other places
where animals are maintained, for extended periods of time. As stated previously, though regular
infections are common they usually do not cause clinical signs due to a buildup of challenge
induced immunity. The trouble with the coccidian species occurs when the immune adult
animals shed fairly large numbers of oocysts on the shared vegetation with naïve calves, which
have yet to endure an initial sensitizing infection. Calves that are immunologically naïve to
coccidian infections can become susceptible to a serious state of disease when placed in highly
contaminated areas and faced with stressful events such as: weaning, shipping, changes in feed,
crowding, and concurrent infections with other parasites. Calves diagnosed with coccidiosis
usually present with bloody diarrhea, dysentery, dehydration, weakness and emaciation (Jolley
and Bardsley, 2006).
Brief history of anthelmintics and their modes of action
In the years that preceded 1960, the anthelmintic products available were not
exceptionally effective at reducing parasite burdens and in some cases were actually harmful to
the health of the animal, with some containing arsenical and nicotine. Some compounds
introduced in the early 1960’s such as morantel tartrate were recognized for their relatively high
level of efficacy against parasitic burdens in livestock, but they are either no longer produced or
used. These products were referred to as the early modern anthelmintics and were soon replaced
by the second generation benzimidazoles in the late 1970s and throughout the 1980s. These
products were used extensively due to their welcomed high level of efficacy against
gastrointestinal nematodes and lungworms while also providing some aid in tapeworm and liver
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fluke control. In 1984, the latest class of deworming products were introduced, and are referred
to as the endectocides meaning that they worked against both internal and external parasites, but
did not have activity against liver flukes or tapeworms. The first product released from this new
drug class of macrocyclic lactones is called ivermectin (Williams and Loyacano, 2001).
The three major classes of anthelmintics that are approved for use in cattle today as
outlined by Edmonds et al. (2010) includes the imidazothiazoles, benzimidazoles and
macrocyclic lactones. Imidazothiazoles used in cattle is limited to the drug known as levamisole.
Benzimidazoles include drugs such as albendazole, fenbendazole, and oxfendazole. The
macrocyclic lactones are subdivided into two groups referred to as the avermectins, which
includes ivermectin, doramectin, eprinomectin , and the milbemycins represented only by
moxidectin in cattle.
Imidazothiazoles mode of action
According to Vercruysse and Claerebout (2019), this class of drugs work by attaching to
nicotinic acetylcholine receptors within the nematode’s nerve cells, resulting in spastic paralysis.
The subsequent paralysis of the nematode allows it to be expelled by the peristalsis action of the
host animal.
Benzimidazoles mode of action
Benzimidazoles work against the nematodes, cestodes, and trematodes by selectively
binding to the heminth’s beta- tubulin molecules, thereby inhibiting microtubule production,
which in turn causes the parasite to slowly die due to loss of intracellular transport mechansisms.
Martin (1997). Inhibition of microtubule formation induces the disruption of cellular transport
and energy metabolism, which in turn depletes energy reserves as well as disrupts the excretion
of waste products. All of these processes work to disrupt the normal bodily processes of the
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parasite, which in turn inhibits its ability to function properly and decreases worm survivability
(Vercruysse and Claerebout, 2019).
Macrocyclic lactones mode of action
The avermectin, and milbemycin subgroups within the macrocyclic lactone class have
minor differences in their molecular properties relative to parasiticidal activieies, but generally
both work against the nematode by increasing the opening of the glutamate gated chloride
(GluCl) channels, which allows for an influx of chloride ions into nervous and muscular tissue.
The influx of these chloride ions causes paralytic effects on different neuromuscular systems
such as the pharynx, reproductive tract and the body wall of the parasite. The paralysis of the
body wall musculature allows the parasite to be immobile, and susceptible to rapid expulsion by
the host animal via peristalsis. Paralysis of the pharynx inhibits the ability of the parasite to feed
which results in worm death by starvation (Vercuysse and Claerebout, 2019).
Anthelmintic resistance
Over the past few decades there has been an observed decrease in the efficacy of
anthelmintics due to an increased resistance by the nematodes to the anthelmintic drugs we rely
on in order to protect our cattle from parasitic infections. Resistance is said to be present when
the frequency of the individuals within a parasite population that would normally be affected by
a dose or the concentration of a compound are no longer affected by that dose or concentration
and require a greater amount for a certain level of efficacy (Wolstenhome et al., 2004).
Resistance is generally confirmed when there is less than 90% reduction in geometric mean
worm count population after treatment administration. (Taylor et al., 2002)
Additionally, it has been reported that multidrug resistance for many species of parasites
has also become a common (Mejia et al., 2003) and that it can be assumed that once resistance is
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observed for one anthelmintic in a class, that there is also some level of resistance to other drugs
in the same class as well (Wolstenhome et al., 2004). Partial contribution to the increased
resistance can be attributed to the fact that many producers strictly rely on drug administration
for worm control, while neglecting husbandry and managerial options such as good pasture
management practices in order to reduce contamination, maintaining refguia in a herd. (Gasbarre
et. al, 2009; Kaplan and Vidyashankar, 2012; Demeler et al., 2010). Resistance is not confined to
the United States, but has become a worldwide concern as resistance has been observed in the
UK, New Zealand, Argentina, and Brazil (Coles, 2002 ; Soutello et al., 2007;Suarez and Cristel ,
2007 ; Kaplan and Vidyashankar , 2012 ; Gasbarre et al., 2009 ; Anziani et al., 2004 ; Chaudhry
et al., 2014).
Cooperia species are perhaps the most often cited as being resistant to the avermectin
drug class. Due to their observed abundance and ability to achieve pathogenic populations in
young cattle, Cooperia infections in calves cause high levels of morbidity and subsequent
mortality that is not curbed with routine anthelminthic intervention (Edmonds et al., 2010; Fiel et
al., 2001; Anziani et al., 2001; Mejia et al., 2003).
In one study, Edmonds et al. (2010) used 50 yearling heifers with a known history of
harboring anthelmintic resistance nematodes. They were treated with either: injectable
ivermectin, injectable moxidectin, oral fenbendazole, oral oxfendazole, or injectable saline
control. Upon necropsy, the results of the trial showed that fenbendazole and oxfendazaole
efficacy against Cooperia spp. was greater than 95% while moxidectin resulted in 88% parasite
reduction and ivermectin treated heifers resulted in no reduction in adult Cooperia spp. These
results show that neither moxidectin or ivermectin were efficacious ( > 90% efficacy) against
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adult Cooperia spp., specifically Cooperia oncophora; further demonstrating the resistance and
dose limiting nature of this species against all drugs of the macrocyclic lactone class.
Anthelmintics of Interest
Moxidectin
As mentioned previously, moxidectin falls into the subclass milbemycin, which is
included in the family of anthelmintics known as the macrocyclic lactones. According to
Vercruysse and Claerebout, (2019) these products are well absorbed when administered orally
and by way of injection whereas when used in formulation as a pour on, the substance has a
more variable absorption within the animal. This particular anthelmintic concentrates within the
adipose tissue of the animal upon administration, which accounts for its ability to sustain
concentrations that allow it to be actively effective against parasites over an extended period of
time.
Performance of cattle treated with Moxidectin
There have been various studies constructed in order to determine the efficacy of
moxidectin (MOX) as an anthelmintic product when used in cattle (Whang et al.1994 ;
Reinmeyer and Cleale, 2002 ; Maritorena-Diez et al., 2005 ; Ives et al.,2007;Walker et al., 2013;
Yazwinski et al.,2013 ; Powell et al.,2008; Cleale et al., 2004). Moxidectin treated cattle have
been observed to have an increase body weight (Walker et al., 2013; Whang et al., 1994) and
increased average daily gain (Cleale et al., 2004; Powell et al., 2008) as compared to controls. A
study conducted by Yazwinski et al. in 2006, observed significant improvements for average
daily gains in cattle receiving MOX injections at multiple dose rates as compared to those
control animals in a combination of three studies which took place in 3 different geographical
locations: Arkansas, Louisiana, and Wisconsin. Regardless of the study location, post-treatment
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interval or the dose rate of moxidectin, a 33% increase in average daily gain in cattle was
observed in treated cattle compared to those that were in the control groups.
Moxidectin effect on fecal egg count reduction
Along with performance data there have been studies that have observed the effects on
fecal egg count reductions in Moxidectin treated cattle when compared to other macrocyclic
lactones (Soutello et al., 2010; Ives et al., 2007; Yazwinski et al., 2013) as well as compared to
control animals (Maritorena-Diez et al., 2005; Cleale et al., 2004; Whang et al., 1994; Powell et
al., 2008). In one study reported by Yazwinksi et al. (2013), 24 study calves that were believed
to have had no prior anthelmintic treatment were blocked into 4 treatment groups: control,
topical ivermectin, topical moxidectin and injectable moxidectin. Two weeks after treatment
administration a fecal egg count reduction test showed a 93% fecal nematode reduction with
injectable moxidectin and upon necropsy (15-18 days post treatment) the topical formulation of
moxidectin resulted in (>90%) efficacy against all common nematodes for cattle.
Eprinomectin extended release formulation
Eprinomectin is a semi-synthetic compound of the avermectin sub group that was
originally formulated for topical administration for the use of nematode, insect, and mite control
in cattle. Due to its capacity to be reformulated into a unique micelle matrix it was formulated as
such and evaluated as well as market as an anthelmintic that would extend the therapeutic
effectiveness in treated animals for prolonged period of time of about 120 days. (Soll et. al,
2013).
One of the driving forces behind the popularity of this extended release product was the
convenience factor for cattle producers. The ability for a single product administration for season
long control of parasites requires less handling, therefore less stress to the animals. The extended
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release formulation consists of a 5% sterile solution of eprinomectin incorporated in a poly (D,
L-lactide-co-glycolic) acid (PGLA) polymer matrix. Following subcutaneous injection at a dose
of 1.0 mg/kg BW, eprinomectin is released from the PGLA matrix at injection site. The
eprinomectin plasma concentrations remain therapeutic for approximately 100 days post
treatment, with an augmenting additional spike at day 70 post treatment. After this second spike,
there is a gradual decline of plasma eprinomectin concentration until approximately day 150
post-original administration. This unique technology of an extended release confers extended
nematode control anywhere from 100-150 days after a single administration (Forbes, 2013).
Performance of cattle treated with Eprinomectin
Eprinomectin has been observed to improve performance parameters of cattle treated
with extended release formulation as opposed to those that were treated with injectable
ivermectin (Andresen et al., 2018) as well as when compared to control animals (Rehbein et al.,
2013).
A study by Andresen et al. (2018), used two experiments to determine performance and
reproductive success of a fall calving beef herd of cows that were treated with either extended
release eprinomectin or conventional injectable ivermectin. In the first experiment, 119 fall
calving cows were assigned to either a treatment of injectable ivermectin (n=53, CONV) or
injectable extended release eprinomectin (n=66, EPR). The performance results of the study
showed that cows treated with EPR observed not only a greater average daily gain, but also a
greater change in body weight (P ≤ 0.01) compared to CONV treated cows. The reproductive
performances observed in the study presented a tendency for higher pregnancy rates in cattle that
were administered EPR as opposed to those in the CONV treatment group (P = 0.15). In addition
to this tendency, it was also observed that the calves of the EPR treated cows had greater
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weaning weights, even at a younger age compared to those calves from the CONV treated cows
(P ≤ 0.01).
In the second experiment in this study, 74 yearling fall replacement heifers were
similarly placed in treatment groups represented by the first experiment (n=33; CONV) or (n=44;
EPR). The performance evaluation showed that EPR treated heifers attained heavier body
weights (P ≤ 0.10), a greater weight gain (P ≤ 0.01), and greater daily gain (P ≤ 0.01) compared
to those heifers administered the CONV treatment. The reproductive performance data in regards
to the heifer treatment groups also revealed that EPR treated heifers overall pregnancy rates were
greater (95%) compared to CONV treated heifers (73%).
Eprinomectin effect on fecal egg count reduction
There have been many studies over the years that have demonstrated a high therapeutic
efficiency and acceptability of extended release eprinomectin (EPR) when used in cattle to treat
multiple species of gastrointestinal and pulmonary nematodes, including those that are inhibited
within the host (Hunter et al., 2013; Rehbein et al., 2013; Soll et al., 2013; Rehbein et al., 2013).
In addition to a record of high therapeutic efficiency against nematode infections, EPR has also
been demonstrated to confer anthelmintic activity for extended periods of time ranging anywhere
from 100-150 days post treatment depending on the species of nematode (Soll et al., 2013;
Rehbein et al., 2013).
A total of 10 studies were used collectively in order to observe the duration of efficacy in
different breeds of cattle in different geographical areas wherein the cattle were challenged with
nematode infections from 100- 150 days following treatment with EPR. Of the 10 studies, 5 took
place in the U.S., 1 took place in the U.K. and 4 took place in Germany. Study 1 and 2 were
created to evaluate efficacy of extended release injectable eprinomectin (EPRI) against nematode
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infections in cattle for 100 to 120 days after treatment, studies 3-8 were created to evaluate
efficacy after 120 days post treatment, and studies 9 and 10 were created to evaluate efficacy
after 150 days post treatment. All studies were conducted by randomized block design based on
pretreatment body weights.
Cattle used to test the efficacy of EPRI against a single challenge of infective stage
gastrointestinal nematodes at 100 days post treatment exhibited an overall nematode reduction of
>99%. Treated cattle had fewer (P < 0.01) nematodes of the species: C. oncophora, C.
surnabada, C. punctata and T. axei as compared to those animals that were treated with control
saline injections.
Cattle used to test the efficacy of EPRI against a single challenge of infective stage
gastrointestinal nematodes and/or lungworms after 120 days post treatment were shown to
exhibit an overall nematode reduction of ≥92%. These treated cattle also had significantly fewer
(P <0.05) of the following species: H. contortus, O. lyrata, O. ostertagi, O. leptospicularis, O.
circumcinta, O. trifurcata, T. axei, C. punctata, B. phlebotomum and O. radiatum, as compared
to the control cattle injected with saline.
Lastly, cattle used to test the efficacy of (EPRI) against a single challenge of infective
stage nematodes at 150 days post treatment were shown to have an overall nematode reduction
of ≥92%. These EPRI treated cattle harbored significantly fewer nematodes (P <0.01) of the
species: H. contortus, B. phlebotomum, O. radiatum, when compared to cattle that were treated
with the saline injection, serving as a control. Therefore, these studies confirmed the high
efficacy of the extended release eprinomectin formulation against nematode challenge at 100,
120, and 150 days following treatment (Soll et al., 2013; Rehbein et al., 2013).
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Fenbendazole
Fenbendazole is a broad spectrum anthelmintic that falls in the benzimidazole drug class
and is most commonly used to treat nematode infections in livestock. It is available in various
formulations such as a bolus, suspension, or paste. It is most commonly administered orally due
to its lack of water solubility, and the ability of the compound to transfer to the parasite by
transcuticular diffusion after absorption through the gastrointestinal tract. (Vercruysse and
Claerebout, 2019; Enejoh and Suleiman, 2017).
Performance of cattle treated with Fenbendazole
In a study conducted by Troxel et al., (1993) fenbendazole (FEN) was administered to
cows in an oral suspension at the rate of 5 mg/kg of body weight, 45 to 60 days prior to calving.
Though the calves born from treated dams had a resulting 15.3 percent increase in ADG
compared to calves born from untreated dams, the observed differences were not deemed
significant.
The results of a two year study conducted by Stromberg et al., (1997) further supports the
idea that cows treated with FEN have increased reproductive performance when compared to
control cows and that calves treated with FEN significantly outgained non-treated control calves.
In the first year of this study, 60 cows and 12 bred heifers were stratified and randomly allocated
to either treated or control groups. Similarly, in the second year of the study, 61 cows and 4 bred
heifers were used in order to compare variances over the successive two years. Cows receiving
anthelminthic treatments were administered an oral fenbendazole suspension at the dose rate of 5
mg/kg of bodyweight just prior to turnout on spring pasture. Control cows did not receive an
anthelmintic treatment. Cows and calves in the treatment groups were administered an oral
fenbendazole suspension at the dose rate of 5 mg/kg of bodyweight at midsummer when moved
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to fresh pastures. Both groups grazed on similar but separate pastures for the duration of the
study. The results of the study had shown an increase (P = 0.0357) in reproductive performance
in the FEN treated cows over the course of the two-year study with an 11.8% and 12.4 %
increased pregnancy rate as compared to the control groups in years 1 and 2 of the study. It was
also observed that the FEN treated calves had an increased average daily gain of 0.13 kg
compared to control calves as well as FEN treated calves weaning at 18.5 kg heavier compared
to those control calves (P = 0.0001).
Fenbendazole effect on fecal egg count reduction
As evidenced by the previously mentioned study by Troxel et al., (1993) FEN was shown
to indirectly decrease fecal egg counts at 90 days of age in calves that were born to cows treated
with FEN prior to calving as compared to those calves born from cows that were left untreated.
Furthermore, Stromberg et al., (1997) observed that FEN treated cows and calves not
only experienced increased performance compared to control animals but also exhibited lower
fecal egg counts throughout the study as well. In his work, control cows experienced higher fecal
egg counts in the collections that occurred in July (P < 0.0001) and October (P = 0.0083) as
compared to the FEN treated cows during the study. The study also reported that calves treated
with FEN had lower fecal egg counts (P < 0.0001) during the October collection at weaning as
compared to control calves.
Economics on deworming beef cattle
In a study using six regional cow- calf operation budgets, Lawrence and Ibarburu (2007)
evaluated the estimated costs of eliminating pharmaceutical products on calf weaning rate and
the subsequent production costs. Of the pharmaceutical technologies investigated in this study,
de-wormer technology had the most significant impact on calf weaning rate, with an expected
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value of 23.6%, which leads to improved weaning rates. It should be noted that weaning rate
includes both pregnancy rate and survival rate of the calf. Also, there was an observed 34%
expected impact on a break even selling price when removing anthelmintic products within a
beef cow calf operation, that correlated to an added cost to the producer of $165.47 per head.
These findings are crucial in understanding the negative impacts that can occur when
withholding anthelmintic treatment, and further convey the importance for continuing research of
anthelmintic efficacy in different beef production systems.
Conclusion
Gastrointestinal nematode infections in cattle have negative impacts on cattle health and
productivity. Proper deworming protocols and fecal egg count reduction tests can be useful in
mitigating these production losses and negative effects on cattle performance when dealing with
parasitic infections.
As stated by Troxel et al., (1993), deworming programs have to take into account the
costs and returns of deworming. Costs may include: the anthelmintic product, equipment, labor,
and the gathering cattle and the returns may include: dam reproduction rates, cutting added
production costs of supplemental feeding products and increased weaning weights in calves.
Producers can properly use commercially available anthelmintic products such as moxidectin,
extended release eprinomectin and fenbendazole as an important tool in order to implement
effective management strategies that are conducive to combating the negative effects of
gastrointestinal nematode infections in their beef cattle herd.
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CHAPTER 1
Evaluation of anthelmintic therapies in a fall calving beef cowherd
INTRODUCTION
It has been reported that conservatively, the economic losses in the cattle industry due to
gastro-intestinal nematode parasitism reaches upwards of $2 billion per year in terms of
productivity losses and increased production expenses, not including the costs associated with
increased labor due to increased animal handling (Stomberg and Gasbarre, 2006). Unfortunately, it
is understood that the actual losses are much greater as this estimation can only factor in observed,
quantifiable losses and does not account for other subclinical losses which are believed to be even
greater than what is actually measurable (Myers, 1988). There are three different forms of internal
parasitism that can affect our cattle which are defined as: infection, economic, and clinical forms.
In this ideology, production losses that are due to the internal parasitic infections in cattle, which
are not apparent to the producers, falls into the economic form. These are believed to greatly
exceed those losses that are obvious by mortality or the state of disease, which would be
considered the clinical form of parasitism. Out of the three forms of parasitism, the economic form
is believed to be by far the most challenging to assess due to the fact that the animal physically
looks healthy, but without comparing performance of treated animals to control animals, the true
impact would still be greatly unknown (Craig, 1988). This underestimation of economic
production losses coupled with increasing resistance to many anthelmintic products poses a major
threat to the ability to maintain the health and productivity of cattle against parasitic infections. Of
the many species of parasites that are a concern for cattle productivity, those that warrant the most
attention are known as the Trichostrongyles.
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Various species within the subfamily Trichostrongylidae have been observed to show
resistance to anthelmintic products of all drug classes due to continuous administration, which
perpetuates selection driven resistance at an accelerated rate. With this knowledge, there has
been much investigation into the commercially available extended release formulation of
eprinomectin, which has a label indicating up to 150 days of efficacy against nematode
infections in cattle after only one injection. This extended activity appears very beneficial for
both the animal and the producer where the animal receives extended protection from parasite
infections due to a “broken” infection process, and the producer saves money in labor costs from
decreased gathering of cattle for treatment. Another advantage of an extended activity
anthelmintic product is the possibility to slow down the rate of resistant nematode generation
turnover with longer periods occurring between treatments compared to other commercially
available products. (Rehbein et al., 2013).
Therefore, the purpose of this study was to evaluate performance and fecal nematode egg
reduction for cows and calves when administered either extended release eprinomectin or
moxidectin anthelmintic therapies just prior to calving; as well as to evaluate performance and
fecal nematode egg reduction for calves administered fenbendazole 55 days prior to weaning.
MATERIALS AND METHODS
Location and Animals
This study was conducted at the University of Arkansas Cow Calf unit in Savoy,
Arkansas and consisted of 106 multiparous beef cows and their respective calves. All cows used
in this study were of an Angus cross breed type. Authorized farm personnel monitored animals
on a daily basis throughout the time of the study. Prior to the beginning of the study, all methods
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and procedures were approved by the University of Arkansas’ Institutional Animal Care and Use
Committee (approval # 19014).
Experimental Design
Cow Management
This study consisted of a randomized block design in which 106 resident fall calving
multiparous beef cows were stratified by weight and parity, before being randomly allocated to 3
different treatment groups: negative control (CON), injectable moxidectin (MOX), and injectable
extended release eprinomectin (ERE). Sample size of cow treatment groups are as follows: CON
(n =38), MOX (n = 30), and ERE (n =38). Cows in the CON group served as negative control
and did not receive any treatment. Cows in the MOX and ERE treatments groups were
administered their respective anthelmintics following label instructions on dose measurements
and route of administration. Cows in the MOX treated group received subcutaneous injections of
1% sterile moxidectin (Cydectin®, Bayer HealthCare LLC, Shawnee Mission, KS) at a dose of
0.2 mg/kg of bodyweight in the cranial portion of the shoulder. Cows in the ERE treated groups
received subcutaneous injections of 5% sterile eprinomectin (LongRange®, Merial Limited,
Duluth, GA) at a dose of 1.0mg/kg of bodyweight in the cranial portion of the shoulder as well.
Treatment was administered one week prior to fall calving in September 2018. Cows were left to
comingle while grazing on permanent pastures throughout the duration of the study, unless being
brought in for days where sampling occurred and with the exception of subgroup pasturing
during the breeding periods. Pastures were primarily comprised of a mixture between warm
season Bermudagrass and cool season endophyte – infected tall Fescue. Unequal cow numbers
in the MOX treatment group compared to the ERE treatment and CON group resulted due to
animal allocation to the study prior to gaining knowledge that some cows within the herd who
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had been previously confirmed pregnant were veritably open, as well as some naturally occurring
calf loss after birth. These animals who were open or who lost calves were removed from the
previously allocated group and therefore were not included in the study.
On d0, cows were brought in from the pastures and processed through a chute to identify
the animal according to its ear tag to confirm treatment group placement. Cows were then treated
with their respective anthelminthic, a fecal sample was obtained, bodyweights (BW) and body
condition scores (BCS) were recorded. All cows were worked through the chute in this fashion
on d 80, d 162, and d 217 of the study with weaning occurring on d 217. All fecal samples were
stored at 4°C prior to being processed for FEC determination, expressed as eggs per gram (EPG).
Calf Allocation
Farm personnel processed 106 Angus crossbred fall born calves from the group of cows
(n = 106) previously included in the study, as mentioned above. The fall calving season occurred
from September 2018 to November 2018, in which time all calves were processed with a unique
identification tag and had their birth weights recorded. Once processing was completed calves
within each dam treatment group were stratified by weight and sex before being randomly
allocated to a group of either negative control (CON) or oral fenbendazole drench (FEN) for later
treatment. Of the 106 fall calves 46 of the calves were female and 60 of the calves were male.
The 38 calves born from the CON group was comprised of 17 female calves and 21 male calves.
The 30 calves born from the MOX group was comprised of 11 female calves and 19 male calves.
The 38 calves born from the ERE group was comprised of 18 female calves and 20 male calves.
Of the 106 processed calves 53 were allocated to the CON group and 53 were allocated to the
FEN group. The CON group was comprised of 22 female calves and 31 male calves while the
FEN group was comprised of 24 female calves and 29 male calves.
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Calf Management
From d 0 to d 80 calves that were born were processed as mentioned above. On d 80 calves were
brought in from the pastures and were individually processed through a chute to identify the
animal according to its ear tag to confirm treatment group placement. Calves, ranging from 1
month to 3 months of age, had their body weights recorded and received respiratory vaccinations
(Pyramid 5 , Boehringer Ingelheim, Vetmedica, Inc.,St. Joseph, MO). On d 162 of the study,
calves ranging from 4 to 6 months of age were worked individually through a chute to record
body weights, obtain fecal samples and be administered anthelmintic treatment according to their
assigned group. Calves that were allocated to controls were not treated and those that were
allocated to FEN group were orally drenched with Fenbendazole (Safeguard®, Intervet Inc.,
Madison, NJ) at 5 mg/kg of body weight. At the time of weaning, d 217 of the study, calves were
again processed through a chute to administer a second round of respiratory vaccinations, record
body weights and obtain fecal samples for fecal egg count quantification. Calf ages ranged from
6 to 8 months of age at the time of weaning. All fecal samples were stored at 4°C prior to being
processed for FEC determination, expressed as eggs per gram (EPG).
Fecal Egg Count
Fecal samples were obtained directly from the rectum, by a poly shoulder length glove
and then compressed to release excess air before sealing. These samples were taken directly to
the University of Arkansas Parasitology lab to be analyzed for a FEC using 1 gram of feces and a
magnesium sulfate (MgSO4) direct centrifugation- floatation technique. This technique was
performed for all cows and calves with cow fecal samples occurring on d 0, 80, 162, 217 and calf
fecal samples occurring on d 162 and 217.One gram of fecal material from each animal was
broken up with metal spatula. Fifteen mL of magnesium sulfate (MgSO4) was added to the feces
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solution and hand homogenized with a metal spatula before straining through a 1 mm aperture
sieve to remove large debris particles. The fecal solution was then placed in 15 mL test tubes and
topped with a coverslip (22× 22 mm) before centrifugation for egg floatation. The coverslip was
then removed and placed on a microscope slide to be viewed for egg quantification using a
microscope at 40x magnification. Eggs were counted and recorded on a per gram basis (EPG).
Statistical Analysis
Quantitative measures for cow data included: BW, BCS, FEC, calving date and calving
rate. Quantitative measures for calf data included: birth weight, BW, ADG, FEC, 205 day
adjusted weaning weight, and gender frequency by treatment. These quantitative measures were
analyzed using a mixed procedure of SAS. Fecal egg count values were transformed into log
FEC values and transformed back to geometric means (GM) by taking the inverse of (log10 (x) 1) for construction of the upcoming tables and figures. A 205 day adjusted weaning weight was
calculated to adjust calf wean weights in order to allow for a fair age equivalent comparison
among calves weaned between the ages of 160 – 250 days of age (Gould , 2015). This was
calculated by using the following equation: (calf WW – calf birth weight)/ (wean date – calving
date) * 205 + calf birth weight. Contrast statements were made for CON vs. Treated and MOX
vs. ERE groups.
Qualitative data such as pregnancy rate and calf gender frequency rate by treatment, was
analyzed using GENMOD with a binomial distribution. Fixed effects for cow data was dam
treatment, day, and day × treatment. The experimental unit was the cow. For calf data fixed
effects were calf treatment, day, dam treatment, calf × dam treatment, and calf treatment × dam
treatment × day. The experimental unit was the calf. All differences were considered with a P ≤
0.05 significance and tendencies were considered at 0.05 ≤ P ≤ 0.10.
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RESULTS
Cow Performance Results
Body Weights (BW)
In this study, weight gain was recorded to determine if treatment with ERE pre calving
would result in greater weight gain than cows treated with MOX. Cow body weights followed a
similar trend of day effect (P < 0.0001) from d 0 to d 217 from the time of calving to weaning
with an average bodyweight of (544.1 ± 4.5 kg) and did not differ (P = 0.97) in regards to a dam
treatment by day interaction. An orthogonal contrast statement revealed no difference of control
versus treatment effect on cow BW (P = 0.38). There was also no observed effect of MOX
treatment versus ERE treatment on cow BW (P > 0.92) ( Table 1; Figure 1). Pooled average
body weight of cows from all treatments on d 0 was (573.8 ± 8.7 kg) and did not differ (P =
0.97). From d 0 to d 80 all cows across treatments lost weight with a pooled average of (530.4 ±
10.8 kg) and did not differ (P = 0.57). From d 80 to d 162 cows across all groups showed similar
gain with a pooled average of (555.2 ± 8.2 kg) and did not differ (P = 0.89). From d 162 to d
217, a similar loss in weight was observed across all treatments with a pooled average of (517.2
± 7.8 kg) and did not differ (P = 0.90). ( Table 1; Figure 1).
Body Condition Scores (BCS)
Cow BCS also followed a similar trend of day effect (P < 0.0001) from d 0 to d 217 from
the time of calving to weaning; with an average BCS of (5.4 ± 0.5), and with no observed
difference on cow treatment by day interaction (P = 0.92).There was, however, an observed
tendency ( P = 0.08) for dam treatment to have an effect on BCS. An orthogonal contrast
statement of control versus treated revealed observed differences (P = 0.03) on cow BCS, where
CON cattle were found to have lower BCS than those treated cattle. An orthogonal contrast
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statement of MOX versus ERE cattle treatment had no observed differences (P = 0.48) on cow
BCS. (Table 2; Figure 2).On d 0 pooled average BCS across all treatments was (6.8 ± 0.1) and
did not differ (P = 0.23). From d 0 to d 80 cows across all treatments experienced a similar loss
of condition with a pooled average BCS of (5.4 ± 0.1) and did not differ (P = 0.82). From d 80 to
d 162 cows across all treatments again experienced a similar loss of condition with a pooled
average BCS of (5.0 ± .1) and did not differ (P = 0.22). Lastly, from d 162 to d 217 cows across
all treatments experienced an even greater loss of condition with a pooled average BCS of (4.3 ±
0.2) and did not differ (P = 0.48). (Table 2; Figure 2).
Cow fecal egg counts
The observed geometric means of cow fecal egg counts were overall lower for ERE
treated cattle (P = 0.003) from d 0 to d 217 of the study where the average FEC for ERE treated
cattle was (1.3 ± 0.1 epg) ; (2.1 ± 0.1 epg) for MOX treated cattle and (2.3 ± 0.1 epg) for CON
cattle. An orthogonal contrast statement of control versus treated revealed observed differences
(P = 0.03) on cow FEC, where CON cattle were found to have higher FEC than those treated
cattle. An orthogonal contrast statement of MOX versus ERE cattle treatment also observed
differences (P = 0.007) on cow FEC, where ERE treated cattle had lower FEC compared to
MOX treated cattle (Table 3). On d 0 pooled average of FEC across all treatments was (2.4 ± 0.2
epg) and did not differ (P > .35). On d 80 control cows had a higher FEC observed than that of
extended release eprinomectin and moxidectin treated cattle (P < 0.0001), but FEC of MOX
treated cattle did not differ from ERE treated cattle (P = 0.16). FEC of treatments are as follows
for ERE, MOX, and CON cows: 1.0 ± 0.1 epg; 1.9 ± 0.1 epg; and 5.0 ± 0.1 epg. On d 162 pooled
average FEC across all treatments was (1.6 ± 0.2 epg) and did not differ (P = 0.40). On d 217
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pooled average FEC across all treatments was (0.9 ± 0.2 epg) and did not differ (P =0.45) (Table
3).
Cow reproductive performance
Cow reproductive performance was measured by data acquired from both fall 2018 and
subsequent 2019 fall calving seasons. Fall 2018 reproductive performance was measured by calf
birth date and gender frequency distribution, while subsequent fall 2019 reproductive
performance was measured by percent pregnant by natural breeding, percent pregnant by
artificial insemination, overall pregnancy rate, subsequent fall calving rate and subsequent fall
2019 calving date. There was no observed difference on fall 2018 calf birth date by dam
treatment (P = 0.96). There were also no observed differences on control versus treated (P =
0.96) or MOX versus ERE (P = 0.79) dam treatment effect on fall 2018 calf birth date (Table 4).
Total herd calf crop which was comprised of calves from CON, MOX and ERE dam treatment
groups yielded 106 calves, which was composed of 43% female calves and 57% male calves. Of
the 38 calves born from the CON dam group, 45% were females and 55% were males. Of the 30
calves born from the MOX dam group, 37 % were females and 63 % were males. Of the 38
calves born from the ERE dam group, 47% were females and 53% were males.
Overall pregnancy rate for the fall 2019 calving season was 84% with pregnancy rates
per treatment group ERE, MOX, and CON cows as follows: 92, 77, and 82 %. There was no
observed anthelmintic effect on pregnancy rates across all treatments (P = 0.17) or effect on
control vs. treated groups (P = 0.55); however, there was an observed tendency (P = 0.07) for
ERE treated cows to have higher pregnancy rates than that of MOX treated cows (Table 5).
Overall calving rate for the fall calving cow herd was 81% with calving rates per treatment group
ERE, MOX, and CON cows as follows: 92, 67, and 82%. There was an observed difference in
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calving rate amongst the three treatments (P = 0.02) where ERE treated cattle had higher calving
rates than those that were treated with MOX (P = 0.007). However, there was no observed
difference in calving rates between control and treated groups (P = 0.87).(Table 5; Figure 3).
There was no observed anthelmintic effect on percent pregnancies confirmed by natural breeding
among treatments (P = 0.29), or by artificial insemination pregnancies (P = 0.17); however, there
was an observed tendency (P = 0.06) for CON cows to have fewer AI confirmed pregnancies
than treated cows. (Figure 4). There was no observed difference in anthelminthic effect on the
following seasons’ calving date (P = 0.23), but there was an observed trend for treated cows to
calve earlier than cows that were left as negative controls (P = 0.11) (Table 6).
Calf performance results
Birth weights
Calf birth weights were similar and did not differ among dam treatments: CON, MOX, or
ERE (P = 0.14). Mean calf birth weights from CON, MOX, and ERE groups were: 32.0 ± 0.8 kg;
32.5 ± 0.9 kg; 34.2 ± 0.8 kg, respectively (Figure 5).
Body Weights (BW)
Calf weights were similar among FEN and CON treatments for d 162 (P = 0.53) and
were not affected by a dam treatment of either CON, MOX, or ERE (P = 0.75). A similar trend
was observed for body weights of FEN and CON calf treatments on d 217 (P = 0.81) and were
again not affected by a dam treatment (P = 0.91). On d 162 CON calves weighed and average of
(179.1 ± 5.4 kg) while FEN treated calves weighed an average of (182.3 ± 5.3 kg). On d 217
CON calves weighed an average of (221.2 ± 10.3 kg) while FEN treated calves weighed an
average of (222.6 ± 10.3 kg) (Figure 6).
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Average Daily Gain (ADG)
Calf ADG was observed to be similar between FEN and CON treatments from d 162 to d
217 (P = 0.47) and was not affected by a dam treatment (P = 0.36). Control calves gained an
average of (0.76 ± 0.1 kg/ day) while FEN treated calves gained an average of (0.73 ± 0.1 kg/
day) (Figure 7).
Calf 205-day adjusted weaning weight
Observed calf 205-day adjusted weaning weights were similar and did not differ among
FEN and CON calves in relation to dam treatment (P = 0.14), calf treatment (P = 0.92), and calf
treatment × dam treatment interaction (P = 0.70). Mean calf 205 day adjusted weaning weight
was (206.5 ± 3.5 kg) for the CON group and (207.0 ± 3.5 kg) for the FEN treated group. An
orthogonal contrast statement for CON versus Treated dams, both MOX and ERE combined, did
reveal a strong tendency (P = 0.0516) for dam treatment to have an effect on calf 205-day
adjusted weaning weights (Figure 8). However, an orthogonal contrast statement of MOX versus
ERE observed no differences (P = 0.93) on 205-day adjusted weaning weight of calves. Mean
205-day adjusted weaning weights of calves according to CON,MOX, and ERE dam treatment
groups were: 200.0 ± 4.1 kg; 209.9 ± 4.7 kg; 210.4 ± 4.1 kg, respectively (Figure 9).
Calf fecal egg counts
Observed calf fecal egg counts were similar (P = 0.19) among FEN and CON treatments
on d 162, where CON calves had an average (9.8 ± 0.1 epg) while FEN treated calves had an
average (12.0 ± 0.1 epg). On d 217, calves in FEN treated and control groups had a similar FEC
(P = 0.79) where CON calves had an average (17.8 ± 0.4 epg) while FEN treated calves had an
average (17.1 ± 0.4 epg) (Figure 10).
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Though FEC were similar among FEN and CON calves in relation to calf treatment on d
162; there was however, an observed tendency for calf FEC to differ in relation to dam treatment
(P = 0.08) . On d 162 calves born from ERE treated dams had a lower FEC than calves born
from CON dams ( P = 0.03) where calves from ERE dams had an average ( 9.3 ± 0.1 epg) and
calves from control dams had an average ( 13.5 ± 0.1 epg). Calves born from MOX treated dams
had an intermediate FEC of (10.1 ± 0.1 epg) that did not differ significantly from the FEC of the
calves from the CON (P = 0.14) or ERE ( P = 0.7) dam groups (Figure 11).
DISCUSSION
Observations of increasing anthelmintic resistance in parasites have driven the
exploration for long-term solutions for nematode control in livestock species. In this study, there
were two objectives: 1.) To evaluate the efficacy of two classes of commercially available
macrocyclic lactones on beef cattle performance over a period of 217 days; 2.) To evaluate the
egg count and performance effects of fenbendazole treated and non- treated control calves 55
days before weaning.
Cow Performance Discussion
In this study, weight gain and body condition scores were evaluated to determine if
treatment with ERE would result in a greater weight gain as compared to animals treated with
MOX or those left as controls. The collection of body weight and condition score changes over a
given time period are important aspects in determining cattle’s nutritional status (Ndlovu et al.,
2007) as well as overall health (Berry et al., 2006) and fertility (Buckley et al., 2003). The
observational trend in similar loss of body weight and body condition score across all cow
treatments in relation to a day effect from d 0 to d 80 is most likely attributed to the period of
calving and peak lactation that occurred during this time frame. Observed similarities in body
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weight and body condition scores across cow treatments throughout the study is most likely
attributed to the low worm burdens reflected by the low fecal egg counts observed in cows across
all groups, indicating only a minor impact of worm infections on animal performance.
Though we did not see sizeable effects of anthelmintic treatment on cow body weights or
body condition scores throughout the duration of the study we did see an effect on cow fecal egg
counts. Although fecal egg counts were considered extremely light throughout the duration of the
study, ERE treated cows had overall lower fecal egg counts compared to MOX and CON cows
throughout the study. On d 80 there was observed differences between CON and anthelminthic
treated cows, where ERE and MOX treated cows had lower FEC than CON cows. Though the
FEC for MOX treated cows was greater than that of ERE treated cows, there were no observed
differences between these two groups. For CON cows these results are most likely attributed to
the further natural pasture infection that would increase in an animal without the use of an
anthelmintic treatment. For MOX treated cows these results would be attributed to the decrease
in internal nematode populations upon initial treatment that would have provided an estimated 14
to 42 days of internal nematode protection as stated in product label claims. This would have
allowed for a reinfection period to occur, prior to secondary fecal collection on d 80. For ERE
treated cows these results would be attributed to the decrease in internal parasitism populations
upon initial treatment that would have provided anywhere from 100-150 days of internal
nematode protection as stated in the product label claims.
As stated in earlier results, dam treatment in fall 2018 prior to calving did not have an
observed effect on fall 2018 calving dates. This is likely attributed to the late phase of gestation
that dams had already reached at the time of treatment administration. It was also stated earlier
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that calf gender frequency distribution among treatments was unaffected by dam treatment in the
fall 2018 calf crop.
Though there were no observed effects of fall 2018 cow treatment on cow reproductive
performance for the fall 2018 calving season, there was observed differences for the subsequent,
fall 2019, calving season. In this study, it was observed that those previously ERE treated cows
with lower FEC had an observed tendency for higher pregnancy rates in the 2019 fall calving
season compared to those previously MOX treated cows. In addition to this, there was also an
observed effect on calving rate, where cows treated with ERE in the previous fall had a higher
fall 2019 calving rate than those treated with MOX. This may indicate that the effect on worm
burdens had a possible effect on dam immunity. If a cow’s immunologic and resilience
homeostatic mechanisms are not being taxed by worm infection, such as in the ERE cattle, then
the cycling cow would have an increased ability to conceive, as disturbed immune function has
been identified as a primary component to infertility (Fair, 2015).
Future studies should focus on the investigation of interactions between fecal egg counts
and immune status within cycling beef cows. The observed tendency which reflects a higher
pregnancy rate and calving rate in ERE treated cows compared to MOX treated cows could be
partly attributed to the fact the sample size of MOX cows in this study was smaller than the CON
and ERE groups. Though there was an observed tendency for higher fall 2019 pregnancy rates in
relation to cow treatment, little effects were observed in relation to proportion of pregnancy
percentage by natural and artificial insemination of cows within treatment groups. Although
there was an observed tendency for CON cows to have fewer A.I. confirmed pregnancies
compared to MOX and ERE groups, upon further investigation into Figure 4, one can see that the
proportion of naturally acquired pregnancies within this group was larger than that of MOX and
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ERE treated groups. Lastly, for cow reproductive performance, it is important to note the
observed trend in calving date differences among cow treatment groups. In this study, there was
an observed trend for CON cows to calve later in the subsequent 2019 calving season compared
to those cows that were treated previously in 2018. Note, that earlier it was stated that in this
study, there was an observation that CON cows also tended to have a lower BCS throughout the
project duration. This may indicate that in this study there was an observed interaction between a
lower BCS and a later subsequent calving date. This interaction is supported by previous
literature (Herd and Sprott,1986) that states a lower BCS post calving prompts an extended
period before a return to estrus, thus extending both the time until a future confirmed pregnancy
and subsequently, the calving interval.
Calf Performance Discussion
In this study, there was no observed difference in FEN treated or CON calves in regards
to body weight or average daily gain over the 55 days prior to weaning. These production
parameters were also unaffected by previous dam treatment, which could be due to the fact that
both dams and calves, in all treatment groups, had low level parasitic infections throughout the
study period.
In this study, there was also no observed effect on calf birth weight, which is again most
likely attributed to the short interval between dam treatment and calf birth. There was however,
observed differences on calf 205-day adjusted calf weaning weight and calf FEC in relation to
dam treatments. In the results, it is observed that the calves born from anthelmintic treated cows
had an additional 9.95 kg of body weight in their 205-day adjusted weaning weight compared to
calves born from CON cows who did not receive any treatment. In addition to this, it was also
observed that calves born from ERE treated cattle had a tendency for lower FEC at d 162 of the
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study compared to calves that were born from CON cows. The implications here are that precalving anthelminthic treatment of the dam could be beneficial in order to increase weaning
weight and curtail calf worm burden in a beef cow calf operation. Both a higher weaning weight
and lower worm burden could lend a hand in a greater immune competence of the calves, which
may enhance their ability to gain weight and fight parasitic infections after the weaning period.
Future studies should investigate if prior dam anthelmintic treatment will go on to affect calf
performance measurements and FEC from the time of birth until the end of the stocker
/beginning of the feedlot phase.
CONCLUSION
In conclusion, though there were not many observed treatment associated differences in
this study, there is still need for further investigations of anthelmintic intervention and resultant
performance of cow calf pairs who are naturally infected with internal parasites. These studies
should include animals with higher, and more common levels of parasitic infection to accomplish
a moderate infection (200 to 800 eggs per gram), in order to get an accurate observation of
parasitic effect on performance prior to treatment. With infection levels similar to these very
light infections observed in this study, it would not be in the producer’s best interest to treat cows
with an anthelminthic. Treatment of animals with anthelminthic products at low infection levels
significantly increases the likelihood of producing genetically resistant worms, while at the same
time not reaping the benefits of curbing economically significant levels of parasitism. However,
a producer should still strive to maintain parasitism below economic thresholds, a scenario that
requires regular treatments.
In the same way that no two cow calf operations are the same, parasitic infections in
livestock between operations can differ greatly as well. Producers must make their own decisions
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to combat internal parasitism within their herd based on their resources, time, and acceptable
associated costs. With the ever increasing prevalence of anthelmintic resistance in our livestock
(Kaplan and Vidyashankar, 2012), it is becoming increasingly more important to strategically
combat internal parasitism by using multifaceted integrated parasite management systems
(Maqbool et al., 2017). Now more than ever the agricultural community can prosper from current
and future studies like this one, which investigates the efficacy of the anthelmintic products
available to ensure animal performance measures are continuing to be met in order to feed our
increasing population both in the U.S. and around the world.
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Table 1. Bodyweight (BW) measurements of fall calving multiparous beef cows treated prior to calving with either Moxidectin or
Extended Release Eprinomectin
_
Item
BW, kg
d0
d80
d162
d217
Overall
a

MOX
575.4
530.4
559.1
520.7
546.4

Treatmentsa
ERE
CON
573.7
539.7
553.7
515.6
545.7

572.1
521.3
552.7
515.4
540.4

SEMb

8.7
10.8
8.2
7.8
4.5

P-Valuec

CON VS TREATEDd

0.97
0.57
0.89
0.90
0.97

CON= control; MOX= moxidectin; ERE= extended release eprinomectin
SEM= pooled SEM
c
Cow BW, total gain, BCS, and FEC were analyzed using MIXED procedures of SAS
d
CON VS TREATED and MOX VS ERE values were analyzed by orthogonal contrasts
*No significant differences were noted
b

0.85
0.99
0.64
0.66
0.38

MOX VS EREd

0.90
0.29
0.94
0.98
0.92
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Eprinomectin or Moxidectin Treatment effect on Mean Dam BW
580
570
560
550

490

ERE

MOX

CON
ERE

MOX

ERE

MOX

CON

CON

500

ERE

CON

510

MOX

ERE

520

MOX

530

CON

BW, kg

540

480
d0

d80

d162

d217

Mean Dam BW from
d0 - d 217

Day

Figure 1. Mean (±SEM) weights (kg) of cow treatment groups: control, injectable moxidectin
(0.2mg/kg of BW); injectable extended release eprinomectin (1mg/kg of BW) recorded on d0,
80, 162, and 217 of the study. N=38 CON; 30 MOX; 38 ERE cows per treatment group.
*No significant differences were noted
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Table 2. Body Condition Score (BCS) measurements of fall calving multiparous beef cows treated prior to calving with either
Moxidectin or Extended Release Eprinomectin
___Treatmentsa
MOX ERE CON

SEMb

P-Valuec

Item
BCSd
d0
6.9
6.8
6.6
0.1
0.23
d80
5.4
5.4
5.3
0.1
0.82
d162
5.1
4.9
4.9
0.1
0.22
d217
4.4
4.4
4.1
0.2
0.48
Overall 5.4x
5.4x
5.2y
0.1
0.08
a
CON= control; MOX= moxidectin; ERE= extended release eprinomectin
b
SEM= pooled SEM
c
COW BW, total gain, BCS, and FEC were analyzed using MIXED procedures of SAS
d
1 to 9 scale; 1= emaciated; 9= obese; (14Wagner et al., 1998)
x,y
Means within a row without common superscripts tended to differ (0.05 < P < 1.0)

CON VS TREATED

0.21
0.74
0.08
0.67
0.03

MOX VS ERE

0.23
0.59
0.83
0.25
0.48
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Eprinomectin or Moxidectin Treatment Effect on Mean Dam
BCS
8
7

a b b

ERE

MOX

CON

ERE

MOX

CON

ERE

MOX

CON

ERE

MOX

2

CON

3

ERE

4

MOX

5

CON

BCS

†

6

1
0
d0

d80

d162

Day

d217

Overall

(P = 0.0808)

Figure 2. Mean (±SEM) BCS of cow treatment groups: control; injectable moxidectin (0.2mg/kg
of BW); injectable extended release eprinomectin (1mg/kg of BW) recorded on d0, 80, 162, and
217 of the study. N=38 CON; 30 MOX; 38 ERE cows per treatment group.
†
BCS measured using 1 to 9 scale; 1= emaciated; 9= obese; (Wagner et al., 1998)
a,b
Means without common superscripts tended to differ (0.05 < P < 0.10)
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Table 3. Fecal egg count (geometric means; GM) treatment × day interaction of fall calving multiparous beef cows treated prior to
calving with either Moxidectin or Extended Release Eprinomectin
Item
Overall FEC, GMc
d0 (calving)
d80
d162
d217 (weaning)
a

Treatmentsa
MOX
ERE CON
d
2.1
1.3e
2.3df
g
g
3.1
2.0
2.2g
1.9hi 1.0ih
5.1j
2.0k
1.3k
1.6k
1.5l
0.9l
1.3l

SEMb
0.1
0.2
0.2
0.2
0.2

CON= control; MOX= moxidectin; ERE= extended release eprinomectin
SEM= pooled SEM
c
FEC= fecal egg counts
d-l
Means within a row without common superscripts differ (P < 0.05)
b

P-Value
0.0031
0.35
<0.0001
0.40
0.45

CON VS TREATED
0.03
0.64
<0.0001
0.88
0.89

MOX VS ERE
0.007
0.16
0.16
0.18
0.22
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Table 4. Fall 2018 average calving date × dam treatment interaction of multiparous beef cows treated prior to calving in fall 2018
with either Moxidectin or Extended Release Eprinomectin
Item
Calving Date
a

Treatmentsa
MOX
ERE
9/25/18

9/26/18

P-Value

CON VS TREATED

MOX VS ERE

CON
9/26/18

0.96

CON= control; MOX= moxidectin; ERE= extended release eprinomectin
*No significant differences were noted

0.96

0.79
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Table 5. Subsequent (fall 2019) reproductive performance measurements of multiparous beef cows treated prior to calving in fall 2018
with either Moxidectin or Extended Release Eprinomectin
Treatmentsa
ERE
CON

SEMb

Item

MOX

Pregnancy
Rate d, %

77

92

82

---

67xz

92y

82zy

---

Calving
Rate c, %
a

CON= control; MOX= moxidectin; ERE= extended release eprinomectin
SEM= pooled SEM
c
Pregnancy rate and calving rate was analyzed using GENMOD
d
Percent cows confirmed pregnant within each treatment
e
Percent cows that calved within each treatment group
x-z
Means within a row without common superscripts differ ( P < 0.05)
b

P-Valuec

CON VS TREATED

MOX VS ERE

0.18

0.55

0.07

0.03

0.87

0.007
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Eprinomectin or Moxidectin Dam Treatment Effect
on Subsequent Fall 2019 Calving Rates

100

c

Percent calving, %

ac
80
ba
60
40

ERE

CON
MOX

20
0
Treatment Group

Figure 3.Mean (±SEM) calving rates of fall calving cow treatment groups control, injectable
moxidectin (0.2mg/kg of BW) ; injectable extended release eprinomectin (1mg/kg of BW). N=38
CON; 30 MOX; 38 ERE cows per treatment group.
a-c
Means without common superscripts differ (P < 0.05)
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Eprinomectin or Moxidectin Dam Treatment Effect on Subsequent Fall
2019 Pregnancy Rate by Natural Breeding and A.I.
c

100%

Percent Pregnant, %

90%

ac

80%
70%

92%

ba

82%

76%

% NAT Preg/ Overall
Preg Rate

60%
50%

% AI Preg / Overall
Preg Rate

40%
30%
20%

37%

45%

10%

66%

56%

Overall Preg Rate

26%

20%

0%
CON

MOX

ERE

Treatment Group

MOX vs. ERE : (P = 0.0735)

Figure 4. Mean (±SEM) pregnancy rates by natural pregnancy and by artificial insemination of
fall calving cow treatment groups control, injectable moxidectin (0.2mg/kg of BW) ; injectable
extended release eprinomectin (1mg/kg of BW). N=38 CON; 30 MOX; 38 ERE cows per
treatment group.
a-c
Means without common superscripts tended to differ (0.05 < P < 1.0)
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Table 6. Subsequent (fall 2019) average calving date × dam treatment interaction of multiparous beef cows treated prior to calving in
fall 2018 with either Moxidectin or Extended Release Eprinomectin
Item
Calving Date
a

Treatmentsa
MOX
ERE
9/16/19

9/20/19

P-Value

CON VS TREATED

MOX VS ERE

CON
9/23/19

0.23

CON= control; MOX= moxidectin; ERE= extended release eprinomectin
*No significant differences were noted

0.11

0.35
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Eprinomectin or Moxidectin Dam Treatment Effect on Calf
Birth Weight
34

Weight, kg

33.5
33
32.5

34

32
32.4
31.5

32

31
CON

MOX

ERE

Treatment

Figure 5.Mean (±SEM) calf birthweight (kg) analyzed by dam treatment. Dam treatments were
CON, n=38; injectable moxidectin (0.2mg/kg of BW) MOX, n= 30; injectable extended release
eprinomectin (1mg/kg of BW) ERE, n= 38.
*No significant differences were noted
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Fenbendazole Treatment Effect on Calf BW 55 Days
Prior to Weaning and at Weaning

250

CON CALVES

150
100
50

CON CALVES

a
FEN CALVES

a
FEN CALVES

200

Weight, kg

b

b

0
d162 (Treatment)

d217 (Weaning)
Day

Figure 6. Mean (±SEM) weights (kg) of calf treatment groups: negative control, CON
(n = 53) and oral drench fenbendazole (5mg/kg of BW), FEN (n = 53) recorded on d162 and
d217 of the study.
a,b
Means without common superscript differ (P < 0.05)

Fenbendazole Treatment Effect on Calf ADG 55 Days
Prior to weaning, and at Weaning

1

Gain, kg/day

0.9
0.8

a

a

0.7
0.6
0.5
0.4

0.73

0.76

CALF ADG

0.3
0.2
0.1
0
FEN CALVES
CON CALVES
Calf Treatment Group

Figure 7. Mean (± SEM) average daily gain (kg/day) of CON (n = 53) and oral drench
fenbendazole (5mg/kg of BW) - FEN (n = 53) calves from d162 - d217 of the study.
*No significant differences were noted
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Control vs. Treated Dam Effect on Calf 205 Day
Adjusted Weaning Weight
212

b

210

Weight, kg

208
206
204
202

209.95

a

200
198

200

196
CON

Treated ( MOX & ERE)

CON vs. Treated : (P = 0.0516)

Figure 8. Mean (±SEM) 205 day adjusted weaning weights of calves analyzed by orthogonal
contrast of control vs. treated in regards to dam treatment. Dam treatments were CON, n=38;
injectable moxidectin (0.2mg/kg of BW) MOX, n= 30; injectable extended release eprinomectin
(1mg/kg of BW) ERE, n= 38.
a,b
Means without common superscripts tended to differ (0.05 < P < 0.10)

212

Eprinomectin or Moxidectin Dam Treatment
Effect on Calf 205 Day Adjusted Weaning Weight

210

Weight, kg

208
206
204
202
200
198
196
CON

MOX

ERE

Dam Treatment

Figure 9. Mean (±SEM) 205 day adjusted weaning weights of calves analyzed by dam treatment.
Dam treatments were CON, n=38; injectable moxidectin (0.2mg/kg of BW) MOX, n= 30;
injectable extended release eprinomectin (1mg/kg of BW) ERE, n= 38.
* No significant differences were noted
57

Calf FEC, eggs per gram

Fenbendazole Treatment effect on Calf FEC 55 Days
Prior to Weaning and at Weaning

14

a
a

10
6

b

b

18

CON

FEN
FEN

CON

2
d162 (Treatment)

d217 (Weaning)

a-bMeans Daycommon

Figure 10. Mean (± SEM) FEC (eggs per gram) from d 162 - d 217 for control (CON), and oral
fenbendazole drench (5mg/kg) (FEN) treated calves.
a,b
Means without common superscripts differ (P < 0.05)

Eprinomectin or Moxidectin Dam Treatment Effect
16

FEC, eggs per gram

14

on D 162 Calf FEC
ab

12

bc

10

c

8
6

CON

MOX

4

ERE

2
0

Dam Treatment
MOX vs. CON: (P = 0.0896)

Figure 11. Mean (±SEM) FEC (eggs per gram) of calves on d 162 analyzed by dam treatment
interaction. Dam treatments were CON, n=38; injectable moxidectin (0.2mg/kg of BW) MOX,
n= 30; injectable extended release eprinomectin (1mg/kg of BW) ERE, n= 38.
a-c
Means without common superscripts tended to differ (0.05 < P < 0.10)
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